SUBSCRIBERS
Ackman is 'profoundly' sorry for US$4b Valeant 'mistake'
Published Thu, Mar 30, 2017 · 09:50 PM
New York
BILL Ackman "deeply and profoundly" apologised for his investment in Valeant Pharmaceuticals International Inc, a "huge mistake" that cost his firm US$4 billion.
In his annual letter to investors in his publicly traded fund Pershing Square Holdings Ltd, Mr Ackman in part blamed Valeant's overpaying for Salix Pharmaceuticals in 2015 for the drugmaker's downfall. But he also took blame for misjudging the company's management and its aggressive strategy.
Share with us your feedback on BT's products and services
more in Consumer & Healthcare
LVMH bets on South Korea to spur growth on US, China uncertainty
Sep 25, 2025 07:31 AM
Fraser and Neave appoints Rahul Colaco as chief executive officer
Sep 25, 2025 12:16 AM
L’Oreal only interested in Armani’s profitable beauty business
Sep 23, 2025 01:11 PM
Netflix signs co-marketing deal with AB InBev to promote TV shows and beer
Sep 22, 2025 09:22 PM
Amazon introduces Whole Foods 365 line to Singapore in brand test
Sep 22, 2025 04:03 PM
China’s consumer price wars are coming for Botox and skincare
Sep 22, 2025 07:45 AM
US regulator sues Ticketmaster over ‘illegal’ ticket schemes
Sep 19, 2025 06:45 AM
Shein opens its supply network to fashion brands to boost growth
Sep 18, 2025 12:26 PM
